Newtox vs Botox: Which Wrinkle Treatment Is Right for You?

Wrinkle-smoothing injectables like Botox have become synonymous with youthful skin. But newer competitors, such as Jeuveau (nicknamed “Newtox”), have entered the market with a promise of similar results—sometimes at a lower price. So, how do Newtox and Botox really compare?

In this guide, we’ll break down the differences and similarities between Newtox and Botox, using clinical data, expert insights, and real patient outcomes to help you make an informed decision.

What Are Botox and Newtox?

Botox (OnabotulinumtoxinA)

Botox is the original FDA-approved botulinum toxin treatment for dynamic wrinkles caused by facial muscle movement. It was first approved in 1989 for medical conditions and 2002 for cosmetic use. Since then, it's become the gold standard for treating:

  • Forehead lines

  • Frown lines (glabellar lines)

  • Crow’s feet

  • Chin dimpling

  • Neck bands

Botox works by temporarily relaxing the muscles responsible for repeated facial expressions, which helps soften and prevent wrinkles.

Jeuveau (Newtox or PrabotulinumtoxinA-xvfs)

Approved by the FDA in 2019, Jeuveau is often called “Newtox” because it’s the newest wrinkle-relaxing neurotoxin on the market. Like Botox, it is a botulinum toxin Type A and is specifically indicated for glabellar (frown) lines.

Jeuveau was developed by Evolus, a company that markets it as a more “modern” and aesthetic-focused alternative to Botox.

Key Differences Between Newtox and Botox

Feature
Botox
Newtox (Jeuveau)
FDA Approval
2002 (cosmetic use)
2019 (cosmetic use)
Type of Toxin
OnabotulinumtoxinA
PrabotulinumtoxinA-xvfs
Manufacturer
AbbVie (formerly Allergan)
Evolus
Focus
Medical and cosmetic
Cosmetic only
Manufacturing Origin
Ireland and U.S. facilities
South Korea
Cost
$12–$20 per unit
$8–$16 per unit (often lower)
Duration of Results
3–4 months
3–4 months (some say faster onset)

Clinical Insight:
Both toxins are very similar in formulation, potency, and effect. However, Newtox is currently only approved for glabellar lines, while Botox has broader FDA-approved cosmetic and therapeutic applications.

How Do They Work?

Both Botox and Newtox block acetylcholine, a neurotransmitter that signals muscle contraction. When injected into specific facial muscles, they cause temporary relaxation, reducing the appearance of dynamic wrinkles.

Important to Know:

  • Neither product “fills” wrinkles (like dermal fillers do)

  • Effects are not immediate—they typically appear within 2–7 days

  • Results last around 3–4 months

What Do the Clinical Studies Say?

Botox: Decades of Data

Botox has been studied extensively with hundreds of clinical trials supporting its efficacy and safety. Some important research includes:

  • A 2003 study published in Dermatologic Surgery found that Botox significantly reduced glabellar lines in over 80% of patients.

  • Long-term data shows that consistent use can actually help prevent new wrinkle formation due to reduced muscle activity.

Newtox: Clinical Trials Show Comparable Results

Newtox underwent FDA-approval through the EV-001 and EV-002 clinical trials, comparing it directly to Botox in randomized, double-blind studies.

Key findings:

  • 67.5% of patients experienced improved glabellar line severity at rest after Newtox treatment vs. 70.4% with Botox.

  • Both were well-tolerated with similar side effect profiles.

  • No significant difference in how long the effects lasted (about 3.6 months on average).

Source: Aesthetic Surgery Journal, 2019 — EV-001 trial

Dr. Sabrina Fabi, MD, board-certified dermatologist:
“In my experience, Jeuveau provides results comparable to Botox for glabellar lines, and some patients even report a slightly faster onset.”

Onset of Action: Which Works Faster?

  • Botox usually begins working within 3–5 days, with full results at 7–10 days.

  • Newtox may begin working as early as 2 days, with peak effects at day 7.

Some anecdotal reports suggest Jeuveau has a slightly faster onset, but this is not consistent across all patients.

How Long Do the Results Last?

Both injectables last around 3 to 4 months, depending on factors like:

  • Metabolism

  • Dose administered

  • Muscle strength in the area

  • Frequency of facial expressions

While some users claim that Botox lasts a bit longer, clinical trials did not show statistically significant differences in longevity between the two products.

Cost Comparison

Treatment
Average Cost per Unit
Typical Units per Area
Total Cost per Treatment
Botox
$12–$20
20–30 units
$240–$600
Newtox
$8–$16
20–30 units
$160–$480

Note: Prices vary by provider, location, and any promotions offered. Jeuveau often comes with rebates or loyalty programs (like Evolus Rewards) which can make it more affordable for cosmetic-only users.

Safety, Side Effects, and Downtime

Both Botox and Newtox are considered very safe when administered by qualified professionals.

Common Side Effects:

  • Temporary redness or swelling at injection site

  • Mild headache

  • Drooping eyelid (rare)

  • Bruising

These effects typically resolve within a few hours to a few days.

Expert Tip from Dr. Rachel Nazarian, MD (Mount Sinai Dept. of Dermatology):
“The safety profile of all botulinum toxin A injectables is excellent. The skill and technique of the injector matter more than which product you choose.”

Newtox vs Botox Comparison Chart

Feature
Botox
Newtox (Jeuveau)
FDA Approval
2002 (cosmetic use)
2019 (cosmetic use)
Botulinum Toxin Type
OnabotulinumtoxinA
PrabotulinumtoxinA-xvfs
Manufacturer
AbbVie
Evolus
Approved Uses
Cosmetic and medical
Cosmetic only
Areas Treated (FDA-approved)
Forehead, crow’s feet, frown lines
Glabellar (frown) lines only
Onset of Action
3–5 days
2–3 days
Duration of Results
3–4 months
3–4 months
Unit Cost (average)
$12–$20
$8–$16
Total Treatment Cost
$240–$600
$160–$480
FDA-Approved Medical Use
Yes
No
Clinical Track Record
20+ years
5+ years
Manufacturing Origin
Ireland / USA
South Korea
Patient Loyalty Program
Allē (Botox)
Evolus Rewards

Important: Botox is FDA-approved for more treatment areas, making it the go-to option for more complex facial rejuvenation. However, many skilled injectors still use Jeuveau off-label in other areas.

Expert & Dermatologist Opinions

Dr. Lara Devgan, Plastic Surgeon (NYC)

“Newtox has become a favorite among my younger patients and first-timers. It’s a great entry-level neuromodulator for glabellar lines.”

Dr. Corey Hartman, Board-Certified Dermatologist

“Botox has more flexibility because of its wide approval base, but Jeuveau gives my cosmetic-only patients another affordable and effective option.”

What Experts Recommend:

  • First-timers or younger patients may prefer Newtox due to cost savings

  • Patients treating multiple facial areas may benefit from Botox’s broader FDA approvals

  • Experienced injectors can use either product off-label based on patient goals

Patient Experiences and Outcomes

Botox Users Say:

  • “My results last a solid 4 months and look very natural.”

  • “I’ve used it for over 5 years and wouldn’t switch.”

Jeuveau (Newtox) Users Say:

  • “It kicked in fast and looked great within 3 days!”

  • “I liked the price, and the results were just as good as Botox.”

  • “I noticed it wore off a bit sooner after 3 months.”

Real-world feedback confirms clinical findings: both treatments work, but personal preferences, injector skill, and cost may guide the final choice.

So… Newtox or Botox? Here’s the Bottom Line:

Factor
Best Choice
Broader FDA uses
Botox
Lower cost
Newtox
Tried-and-true
Botox
Modern cosmetic focus
Newtox
Off-label versatility
Botox
First-time users
Newtox


Final Thoughts

Botox remains the industry leader with a longer track record, broader approvals, and high patient satisfaction. But Jeuveau—aka Newtox—is a strong, effective alternative, especially for cosmetic-only users looking for glabellar line treatment at a more affordable price.

The best choice ultimately depends on:

  • Your treatment goals

  • Budget

  • Injector’s experience with the product

  • Whether you're targeting one area or multiple zones

If you’re unsure, consult a board-certified dermatologist or aesthetic provider experienced in both products. They can assess your facial anatomy, expression patterns, and treatment history to help guide you toward the right neuromodulator.

References

  1. Aesthetic Surgery Journal, “Efficacy and Safety of PrabotulinumtoxinA-xvfs for the Treatment of Glabellar Lines: Results from the EV-001 Trial” (2019)

  2. American Academy of Dermatology

  3. Dr. Lara Devgan Plastic Surgery – Patient Treatment Protocols

  4. Mount Sinai Health System – Dermatology Clinical Research

  5. BotoxCosmetic.com & Evolus.com (manufacturer data)




skinbravo editorial coverage

SkinBravo delivers research-driven skincare insights. Our editorial board curates evidence-based information to guide informed decisions.

skinbravo affiliate disclosure

SkinBravo may earn a small commission from some links on this site when you buy products, at no additional cost. This helps us keep sharing trusted, research-based content.

You may also like